Extensive Mesenteric Excision (EME) Versus Local Mesenteric Excision (LME) for Crohn's Disease
- Conditions
- Postoperative Disease RecurrenceCrohns Disease
- Interventions
- Procedure: mesenteric excision
- Registration Number
- NCT02542904
- Lead Sponsor
- Jinling Hospital, China
- Brief Summary
Crohn's patients receiving ileocolonic resection are randomized into extensive mesenteric resection group and local mesenteric resection group.
- Detailed Description
Randomization was performed intraoperatively once the surgeon had determined that there were no other sites of disease and that either type of anastomosis could be performed safely. Computer generated randomization was carried out within strata using randomized permuted blocks to ensure balance of the groups.
All surgery was performed by a single group of surgeons experienced in the surgical treatment of Crohn's disease. Surgery was performed open or laparoscopically depending on patient factors and surgeon preference. The resection was performed grossly normal resection margins, with side-to-side anastomosis. The presence of mesenteric marginal thickening with confirmation by naked eye assessment of the mucosal aspect of the bowel were used to establish the limits of the disease.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 119
- Crohn's disease limited to the distal ileum and/or right colon
- Concomitant anastomosis/strictureplasty at another site of the gastrointestinal tract, and required a temporary fecal diversion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description EME mesenteric excision the anastomosis was performed as a stapled side-to-side anastomosis with extensive excision of mesenteric tissue. LME mesenteric excision the anastomosis was performed as stapled side-to-side with local excision of the mesenteric tissue adjacent to the diseased bowel
- Primary Outcome Measures
Name Time Method postoperative endoscopic recurrence 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Jinling Hospital
🇨🇳Nanjing, Jiangsu, China